Novel depsipeptide compound
CA 2497281 A1 · Owner: Taniguchi, Masatoshi · Inventors: Mori, Masamichi; Takahashi, Isao; Shindo, Nobuaki
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A novel compound which is useful as a preventive or a remedy for diseases in which HDAC participates, in particular tumor and cell proliferative diseases. A depsipeptide compound or its pharmaceutically acceptable salt has a favorable HDAC inhibitory effect and an activity of inhibiting the proliferation of human cancer cells and therefore, is useful in treating and , improving diseases and pathogenic conditions in which histone acetylation participates, in particular, tumor and cell proliferative diseases.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 28, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 28, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 28, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.